GOOGL   1,423.51 (+0.37%)
AMZN   2,411.53 (+0.43%)
CGC   17.44 (-19.71%)
BABA   199.59 (+0.05%)
MU   46.34 (-0.28%)
GE   6.55 (-3.39%)
TSLA   807.16 (+0.17%)
AMD   51.74 (+0.00%)
GILD   75.42 (+0.13%)
DIS   116.02 (-0.63%)
GOOGL   1,423.51 (+0.37%)
AMZN   2,411.53 (+0.43%)
CGC   17.44 (-19.71%)
BABA   199.59 (+0.05%)
MU   46.34 (-0.28%)
GE   6.55 (-3.39%)
TSLA   807.16 (+0.17%)
AMD   51.74 (+0.00%)
GILD   75.42 (+0.13%)
DIS   116.02 (-0.63%)
GOOGL   1,423.51 (+0.37%)
AMZN   2,411.53 (+0.43%)
CGC   17.44 (-19.71%)
BABA   199.59 (+0.05%)
MU   46.34 (-0.28%)
GE   6.55 (-3.39%)
TSLA   807.16 (+0.17%)
AMD   51.74 (+0.00%)
GILD   75.42 (+0.13%)
DIS   116.02 (-0.63%)
GOOGL   1,423.51 (+0.37%)
AMZN   2,411.53 (+0.43%)
CGC   17.44 (-19.71%)
BABA   199.59 (+0.05%)
MU   46.34 (-0.28%)
GE   6.55 (-3.39%)
TSLA   807.16 (+0.17%)
AMD   51.74 (+0.00%)
GILD   75.42 (+0.13%)
DIS   116.02 (-0.63%)
Log in

NASDAQ:STOKStoke Therapeutics News Headlines

$26.88
-0.03 (-0.11 %)
(As of 05/29/2020 09:34 AM ET)
Add
Compare
Today's Range
$26.88
Now: $26.88
$26.88
50-Day Range
$20.26
MA: $23.62
$29.73
52-Week Range
$15.82
Now: $26.88
$39.04
Volume886 shs
Average Volume95,887 shs
Market Capitalization$886.23 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Stoke Therapeutics (NASDAQ STOK) News Headlines

Source:
DateHeadline
Insider Selling: Stoke Therapeutics (NASDAQ:STOK) EVP Sells 7,500 Shares of StockInsider Selling: Stoke Therapeutics (NASDAQ:STOK) EVP Sells 7,500 Shares of Stock
www.americanbankingnews.com - May 26 at 10:34 PM
Stoke Therapeutics (STOK) "Buy" Rating Reiterated at HC WainwrightStoke Therapeutics' (STOK) "Buy" Rating Reiterated at HC Wainwright
www.americanbankingnews.com - May 19 at 6:38 AM
Stoke Therapeutics (NASDAQ:STOK) Announces  Earnings Results, Beats Estimates By $0.02 EPSStoke Therapeutics (NASDAQ:STOK) Announces Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - May 16 at 1:01 PM
BRIEF-Stoke Therapeutics Reports Q1 Financial ResultsBRIEF-Stoke Therapeutics Reports Q1 Financial Results
www.reuters.com - May 15 at 10:45 PM
Stoke Therapeutics Inc.Stoke Therapeutics Inc.
www.barrons.com - May 15 at 5:45 PM
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business UpdatesStoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
finance.yahoo.com - May 15 at 7:44 AM
Stoke Therapeutics (NASDAQ:STOK) Sees Significant Growth in Short InterestStoke Therapeutics (NASDAQ:STOK) Sees Significant Growth in Short Interest
www.americanbankingnews.com - May 14 at 9:56 AM
Stoke Therapeutics Presents Preclinical Data That Demonstrate In-Vitro and In-Vivo Target Engagement and Protein Upregulation in OPA1 Protein Deficiency, the Primary Cause of the Most Common Inherited Optic Nerve DisorderStoke Therapeutics Presents Preclinical Data That Demonstrate In-Vitro and In-Vivo Target Engagement and Protein Upregulation in OPA1 Protein Deficiency, the Primary Cause of the Most Common Inherited Optic Nerve Disorder
finance.yahoo.com - May 12 at 2:26 PM
Stoke Therapeutics (NASDAQ:STOK) Given Average Recommendation of "Buy" by BrokeragesStoke Therapeutics (NASDAQ:STOK) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 12 at 7:07 AM
Stoke Therapeutics Reports Full Year 2019 Financial Results and Provides Business UpdatesStoke Therapeutics Reports Full Year 2019 Financial Results and Provides Business Updates
finance.yahoo.com - March 23 at 1:00 PM
Stoke Therapeutics to Present at 40th Annual Cowen Health Care ConferenceStoke Therapeutics to Present at 40th Annual Cowen Health Care Conference
finance.yahoo.com - February 24 at 9:31 AM
Slaven Bilic handed big West Brom boost ahead of Stoke City clashSlaven Bilic handed big West Brom boost ahead of Stoke City clash
www.msn.com - January 18 at 12:31 PM
So much better - The Stoke City view ahead of West Brom test'So much better' - The Stoke City view ahead of West Brom test
www.msn.com - January 18 at 12:31 PM
Stoke Therapeutics to Present at 38th Annual J.P. Morgan Healthcare ConferenceStoke Therapeutics to Present at 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 5:30 PM
Stoke Therapeutics Added to NASDAQ Biotechnology IndexStoke Therapeutics Added to NASDAQ Biotechnology Index
finance.yahoo.com - December 23 at 2:32 PM
Biotech startups Stoke flames of Mass. IPOs once againBiotech startups Stoke flames of Mass. IPO's once again
www.bizjournals.com - December 20 at 8:21 AM
Hedge Funds Are Selling Stoke Therapeutics, Inc. (STOK)Hedge Funds Are Selling Stoke Therapeutics, Inc. (STOK)
finance.yahoo.com - December 19 at 9:54 PM
Stoke Therapeutics: Seizure Data Just In Time For The Lock-Up Expiration, Sell Before Insiders DoStoke Therapeutics: Seizure Data Just In Time For The Lock-Up Expiration, Sell Before Insiders Do
seekingalpha.com - December 13 at 12:24 PM
Stoke Therapeutics Presents Preclinical Data on the Biodistribution, Target Engagement and Safety of STK-001 in Non-Human Primates That Support the Planned Clinical Development of STK-001 for the Treatment of Dravet SyndromeStoke Therapeutics Presents Preclinical Data on the Biodistribution, Target Engagement and Safety of STK-001 in Non-Human Primates That Support the Planned Clinical Development of STK-001 for the Treatment of Dravet Syndrome
finance.yahoo.com - December 8 at 11:33 AM
Stoke Therapeutics Presents Preclinical Data From Studies of STK-001 That Showed Improvements in Survival and Reductions in Seizure Frequency in a Mouse Model of Dravet SyndromeStoke Therapeutics Presents Preclinical Data From Studies of STK-001 That Showed Improvements in Survival and Reductions in Seizure Frequency in a Mouse Model of Dravet Syndrome
www.businesswire.com - December 7 at 12:36 PM
Stoke Therapeutics to Present at Piper Jaffray 31st Annual Healthcare ConferenceStoke Therapeutics to Present at Piper Jaffray 31st Annual Healthcare Conference
finance.yahoo.com - November 26 at 4:21 PM
Stoke Therapeutics to Present New Preclinical Data on STK-001 at the American Epilepsy Society Annual MeetingStoke Therapeutics to Present New Preclinical Data on STK-001 at the American Epilepsy Society Annual Meeting
finance.yahoo.com - November 25 at 3:35 PM
Can The Uptrend Continue for Stoke Therapeutics?Can The Uptrend Continue for Stoke Therapeutics?
finance.yahoo.com - November 22 at 7:51 AM
Stoke Therapeutics EPS beats by $0.02Stoke Therapeutics EPS beats by $0.02
seekingalpha.com - November 12 at 8:47 AM
Stoke Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business UpdateStoke Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - November 12 at 8:47 AM
Stoke Therapeutics to Present at Upcoming Investor Conferences in NovemberStoke Therapeutics to Present at Upcoming Investor Conferences in November
finance.yahoo.com - November 5 at 1:20 PM
Will Stoke Therapeutics Continue to Surge Higher?Will Stoke Therapeutics Continue to Surge Higher?
finance.yahoo.com - November 1 at 2:44 PM
Stoke Therapeutics Strengthens Leadership Team With Appointments of Robin A. Walker, J.D., as Senior Vice President, Chief LegalStoke Therapeutics Strengthens Leadership Team With Appointments of Robin A. Walker, J.D., as Senior Vice President, Chief Legal
www.bloomberg.com - October 16 at 9:17 AM
Stoke Therapeutics Strengthens Leadership Team With Appointments of Robin A. Walker, J.D., as Senior Vice President, Chief Legal Officer and Joan Wood as Head of Human ResourcesStoke Therapeutics Strengthens Leadership Team With Appointments of Robin A. Walker, J.D., as Senior Vice President, Chief Legal Officer and Joan Wood as Head of Human Resources
finance.yahoo.com - October 16 at 9:17 AM
Why Shares of Stoke Therapeutics Plummeted in SeptemberWhy Shares of Stoke Therapeutics Plummeted in September
www.fool.com - October 8 at 6:53 PM
Stoke Therapeutics to Present at 2019 Cantor Global Healthcare ConferenceStoke Therapeutics to Present at 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 30 at 5:01 PM
We're Not Very Worried About Stoke Therapeutics's (NASDAQ:STOK) Cash Burn RateWe're Not Very Worried About Stoke Therapeutics's (NASDAQ:STOK) Cash Burn Rate
finance.yahoo.com - September 20 at 5:25 PM
Stoke Therapeutics Added to Russell 2000 and 3000 IndexesStoke Therapeutics Added to Russell 2000 and 3000 Indexes
finance.yahoo.com - September 11 at 12:55 PM
3 New Biotech Stocks That Keep On Soaring3 New Biotech Stocks That Keep On Soaring
finance.yahoo.com - September 7 at 12:10 PM
Stoke Therapeutics Enrolls First Patient in an Observational Study of Children and Adolescents Living with Dravet SyndromeStoke Therapeutics Enrolls First Patient in an Observational Study of Children and Adolescents Living with Dravet Syndrome
www.businesswire.com - August 20 at 8:38 AM
Stoke Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business UpdateStoke Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - August 14 at 11:41 AM
Stoke Therapeutics Granted FDA Orphan Drug Designation for STK-001, an Investigational New Treatment for Dravet SyndromeStoke Therapeutics Granted FDA Orphan Drug Designation for STK-001, an Investigational New Treatment for Dravet Syndrome
finance.yahoo.com - August 6 at 3:21 PM
IPO Pops Proliferate as Two More Firms Surge 50%IPO Pops Proliferate as Two More Firms Surge 50%
finance.yahoo.com - June 28 at 3:15 PM
Stoke Therapeutics shares soar 46% in trading debutStoke Therapeutics shares soar 46% in trading debut
finance.yahoo.com - June 24 at 3:16 PM
Stoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesStoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - June 24 at 3:16 PM
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.